Bausch Health Cos., Inc.
(Toronto Stock Exchange : BHC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
-2.17%21.271.8%$147.03m
MDCOMedicines Company
-1.35%36.5021.8%$74.55m
ARQLArQule, Inc.
-1.98%10.410.7%$66.06m
JAZZJazz Pharmaceuticals Plc
0.20%136.882.3%$65.72m
PRGOPerrigo Co. Plc
0.06%50.406.8%$60.19m
SAGESAGE Therapeutics, Inc.
-0.26%179.798.7%$53.51m
UTHRUnited Therapeutics Corporation
-0.05%75.8814.3%$48.88m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-2.56%161.986.2%$43.72m
HZNPHorizon Pharma plc
-0.63%23.696.7%$42.54m
CTLTCatalent Inc
-0.22%53.622.4%$39.59m
ICLRICON Plc
0.05%150.194.1%$34.16m
ICPTIntercept Pharmaceuticals, Inc.
0.32%68.9118.6%$33.19m
AXSMAxsome Therapeutics, Inc.
-1.92%25.082.1%$23.90m
PTLAPortola Pharmaceuticals, Inc.
-0.82%25.477.5%$22.67m
ENDPEndo International Plc
-2.30%3.618.8%$19.91m

Company Profile

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.